BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma

Overview of attention for article published in Blood and Lymphatic Cancer: Targets and Therapy, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

news: 1 news outlet
twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 36 Mendeley

Summary News X Patents Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Prevalence of the t(11; 14)(q13; q32) immunoglobulin H/CCND1 in Mexican mestizos with multiple myeloma: A single institution experience

Article in Iraqi Journal of Hematology (February 2024)

Exploring Novel Anticancer Peptides: Evolutionary Prediction of Potential tRNA-Encoded Peptides for Targeted Therapies

Conference proceeding (January 2024)

Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma

Article in Life Sciences (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.